U.S. Markets close in 46 mins.

pSivida Corp. (PSDV)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.11-0.03 (-1.40%)
As of 3:14PM EDT. Market open.
People also watch
ALIMPRANOPXAPSTIBDSI
Interactive chart
Previous Close2.14
Open2.14
Bid2.10 x 1200
Ask2.12 x 1100
Day's Range2.02 - 2.14
52 Week Range1.50 - 4.25
Volume510,860
Avg. Volume372,603
Market Cap83.04M
Beta-1.75
PE Ratio (TTM)-3.85
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to pSivida Corp. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube14 days ago

    ETFs with exposure to pSivida Corp. : May 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2017 By the Numbers : May 10, 2017
    Capital Cube15 days ago

    pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., Abbott Laboratories, Merck & Co., Inc. and Pfizer Inc. (REGN-US, ALIM-US, ABT-US, MRK-US and PFE-US) that have also reported for ... Read more (Read more...)